1. Home
  2. AVNT vs FOLD Comparison

AVNT vs FOLD Comparison

Compare AVNT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avient Corporation

AVNT

Avient Corporation

HOLD

Current Price

$30.38

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$10.75

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNT
FOLD
Founded
1927
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
1993
2007

Fundamental Metrics

Financial Performance
Metric
AVNT
FOLD
Price
$30.38
$10.75
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$45.67
$30.29
AVG Volume (30 Days)
745.8K
4.6M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
3.49%
N/A
EPS Growth
N/A
N/A
EPS
1.23
N/A
Revenue
$3,246,100,000.00
$598,704,000.00
Revenue This Year
$2.24
$21.49
Revenue Next Year
$2.48
$18.25
P/E Ratio
$25.16
N/A
Revenue Growth
1.03
21.28
52 Week Low
$27.48
$5.51
52 Week High
$49.23
$11.00

Technical Indicators

Market Signals
Indicator
AVNT
FOLD
Relative Strength Index (RSI) 49.93 77.41
Support Level $29.86 $9.73
Resistance Level $31.83 $10.05
Average True Range (ATR) 0.87 0.36
MACD 0.16 0.04
Stochastic Oscillator 46.14 77.53

Price Performance

Historical Comparison
AVNT
FOLD

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: